Olanzapine Injection, Powder, For Solution
Product Images NDC 72843-576

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 72843-576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ubi Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Olanzapine for Injection 10 mg/vial)

Packaging label for Olanzapine Intramuscular injection, powder for solution, 10 mg/vial. The single-dose vial is labeled for intramuscular use only and marketed by UBI Pharma Inc. Storage instructions specify controlled room temperature conditions before and after reconstitution. The label includes barcode and NDC 72843-576-01.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure of Olanzapine, the active ingredient in Olanzapine Intramuscular injection, powder, for solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.